1H7X
Dihydropyrimidine dehydrogenase (DPD) from pig, ternary complex of a mutant enzyme (C671A), NADPH and 5-fluorouracil
External Resource: Annotation
Domain Annotation: SCOP/SCOPe Classification SCOP-e Database Homepage
Domain Annotation: SCOP2 Classification SCOP2 Database Homepage
Chains | Type | Family Name | Domain Identifier | Family Identifier | Provenance Source (Version) |
---|---|---|---|---|---|
A | SCOP2B Superfamily | Thioredoxin reductase-like | 8017506 | 3000050 | SCOP2B (2022-06-29) |
A | SCOP2B Superfamily | FMN-linked oxidoreductases | 8001523 | 3000014 | SCOP2B (2022-06-29) |
A | SCOP2B Superfamily | 4Fe-4S ferredoxins | 8001525 | 3000020 | SCOP2B (2022-06-29) |
A | SCOP2B Superfamily | alpha-helical ferredoxin | 8001521 | 3000026 | SCOP2B (2022-06-29) |
D | SCOP2B Superfamily | alpha-helical ferredoxin | 8001521 | 3000026 | SCOP2B (2022-06-29) |
D | SCOP2B Superfamily | FMN-linked oxidoreductases | 8001523 | 3000014 | SCOP2B (2022-06-29) |
D | SCOP2B Superfamily | 4Fe-4S ferredoxins | 8001525 | 3000020 | SCOP2B (2022-06-29) |
D | SCOP2B Superfamily | Thioredoxin reductase-like | 8017506 | 3000050 | SCOP2B (2022-06-29) |
B | SCOP2B Superfamily | Thioredoxin reductase-like | 8017506 | 3000050 | SCOP2B (2022-06-29) |
B | SCOP2B Superfamily | alpha-helical ferredoxin | 8001521 | 3000026 | SCOP2B (2022-06-29) |
B | SCOP2B Superfamily | FMN-linked oxidoreductases | 8001523 | 3000014 | SCOP2B (2022-06-29) |
B | SCOP2B Superfamily | 4Fe-4S ferredoxins | 8001525 | 3000020 | SCOP2B (2022-06-29) |
C | SCOP2B Superfamily | 4Fe-4S ferredoxins | 8001525 | 3000020 | SCOP2B (2022-06-29) |
C | SCOP2B Superfamily | alpha-helical ferredoxin | 8001521 | 3000026 | SCOP2B (2022-06-29) |
C | SCOP2B Superfamily | FMN-linked oxidoreductases | 8001523 | 3000014 | SCOP2B (2022-06-29) |
C | SCOP2B Superfamily | Thioredoxin reductase-like | 8017506 | 3000050 | SCOP2B (2022-06-29) |
Domain Annotation: ECOD Classification ECOD Database Homepage
Chains | Family Name | Domain Identifier | Architecture | Possible Homology | Homology | Topology | Family | Provenance Source (Version) |
---|---|---|---|---|---|---|---|---|
A | Fer4_20 | e1h7xA1 | A: alpha arrays | X: alpha-helical ferredoxin-like | H: alpha-helical ferredoxin (From Topology) | T: alpha-helical ferredoxin | F: Fer4_20 | ECOD (1.6) |
A | Fer4_21 | e1h7xA2 | A: a+b two layers | X: 4Fe-4S ferredoxin (From Topology) | H: 4Fe-4S ferredoxin (From Topology) | T: 4Fe-4S ferredoxin | F: Fer4_21 | ECOD (1.6) |
A | DHO_dh | e1h7xA3 | A: a/b barrels | X: TIM beta/alpha-barrel | H: TIM barrels (From Topology) | T: TIM barrels | F: DHO_dh | ECOD (1.6) |
A | Pyr_redox_2_3 | e1h7xA4 | A: a/b three-layered sandwiches | X: Rossmann-like | H: Rossmann-related | T: FAD/NAD(P)-binding domain | F: Pyr_redox_2_3 | ECOD (1.6) |
A | Pyr_redox_2 | e1h7xA5 | A: a/b three-layered sandwiches | X: Rossmann-like | H: Rossmann-related | T: Nucleotide-binding domain | F: Pyr_redox_2 | ECOD (1.6) |
D | Fer4_20 | e1h7xD1 | A: alpha arrays | X: alpha-helical ferredoxin-like | H: alpha-helical ferredoxin (From Topology) | T: alpha-helical ferredoxin | F: Fer4_20 | ECOD (1.6) |
D | Fer4_21 | e1h7xD2 | A: a+b two layers | X: 4Fe-4S ferredoxin (From Topology) | H: 4Fe-4S ferredoxin (From Topology) | T: 4Fe-4S ferredoxin | F: Fer4_21 | ECOD (1.6) |
D | DHO_dh | e1h7xD3 | A: a/b barrels | X: TIM beta/alpha-barrel | H: TIM barrels (From Topology) | T: TIM barrels | F: DHO_dh | ECOD (1.6) |
D | Pyr_redox_2_3 | e1h7xD4 | A: a/b three-layered sandwiches | X: Rossmann-like | H: Rossmann-related | T: FAD/NAD(P)-binding domain | F: Pyr_redox_2_3 | ECOD (1.6) |
D | Pyr_redox_2 | e1h7xD5 | A: a/b three-layered sandwiches | X: Rossmann-like | H: Rossmann-related | T: Nucleotide-binding domain | F: Pyr_redox_2 | ECOD (1.6) |
B | Fer4_20 | e1h7xB1 | A: alpha arrays | X: alpha-helical ferredoxin-like | H: alpha-helical ferredoxin (From Topology) | T: alpha-helical ferredoxin | F: Fer4_20 | ECOD (1.6) |
B | Fer4_21 | e1h7xB2 | A: a+b two layers | X: 4Fe-4S ferredoxin (From Topology) | H: 4Fe-4S ferredoxin (From Topology) | T: 4Fe-4S ferredoxin | F: Fer4_21 | ECOD (1.6) |
B | DHO_dh | e1h7xB3 | A: a/b barrels | X: TIM beta/alpha-barrel | H: TIM barrels (From Topology) | T: TIM barrels | F: DHO_dh | ECOD (1.6) |
B | Pyr_redox_2_3 | e1h7xB4 | A: a/b three-layered sandwiches | X: Rossmann-like | H: Rossmann-related | T: FAD/NAD(P)-binding domain | F: Pyr_redox_2_3 | ECOD (1.6) |
B | Pyr_redox_2 | e1h7xB5 | A: a/b three-layered sandwiches | X: Rossmann-like | H: Rossmann-related | T: Nucleotide-binding domain | F: Pyr_redox_2 | ECOD (1.6) |
C | Fer4_20 | e1h7xC1 | A: alpha arrays | X: alpha-helical ferredoxin-like | H: alpha-helical ferredoxin (From Topology) | T: alpha-helical ferredoxin | F: Fer4_20 | ECOD (1.6) |
C | Fer4_21 | e1h7xC2 | A: a+b two layers | X: 4Fe-4S ferredoxin (From Topology) | H: 4Fe-4S ferredoxin (From Topology) | T: 4Fe-4S ferredoxin | F: Fer4_21 | ECOD (1.6) |
C | DHO_dh | e1h7xC3 | A: a/b barrels | X: TIM beta/alpha-barrel | H: TIM barrels (From Topology) | T: TIM barrels | F: DHO_dh | ECOD (1.6) |
C | Pyr_redox_2_3 | e1h7xC4 | A: a/b three-layered sandwiches | X: Rossmann-like | H: Rossmann-related | T: FAD/NAD(P)-binding domain | F: Pyr_redox_2_3 | ECOD (1.6) |
C | Pyr_redox_2 | e1h7xC5 | A: a/b three-layered sandwiches | X: Rossmann-like | H: Rossmann-related | T: Nucleotide-binding domain | F: Pyr_redox_2 | ECOD (1.6) |
Domain Annotation: CATH CATH Database Homepage
Protein Family Annotation Pfam Database Homepage
Chains | Accession | Name | Description | Comments | Source |
---|---|---|---|---|---|
PF07992 | Pyridine nucleotide-disulphide oxidoreductase (Pyr_redox_2) | Pyridine nucleotide-disulphide oxidoreductase | This family includes both class I and class II oxidoreductases and also NADH oxidases and peroxidases. This domain is actually a small NADH binding domain within a larger FAD binding domain. | Domain | |
PF01180 | Dihydroorotate dehydrogenase (DHO_dh) | Dihydroorotate dehydrogenase | - | Domain | |
PF14691 | Dihydroprymidine dehydrogenase domain II, 4Fe-4S cluster (Fer4_20) | Dihydroprymidine dehydrogenase domain II, 4Fe-4S cluster | Domain II of the enzyme dihydroprymidine dehydrogenase binds FAD. Dihydroprymidine dehydrogenase catalyses the first and rate-limiting step of pyrimidine degradation by converting pyrimidines to the corresponding 5,6- dihydro compounds [1]. This doma ... | Domain | |
PF14697 | 4Fe-4S dicluster domain (Fer4_21) | 4Fe-4S dicluster domain | Superfamily includes proteins containing domains which bind to iron-sulfur clusters. Members include bacterial ferredoxins, various dehydrogenases, and various reductases. Structure of the domain is an alpha-antiparallel beta sandwich. Domain contai ... | Domain |
Gene Ontology: Gene Product Annotation Gene Ontology Database Homepage
InterPro: Protein Family Classification InterPro Database Homepage
Chains | Accession | Name | Type |
---|---|---|---|
IPR013785 | Aldolase-type TIM barrel | Homologous Superfamily | |
IPR005720 | Dihydroorotate dehydrogenase, catalytic | Domain | |
IPR036188 | FAD/NAD(P)-binding domain superfamily | Homologous Superfamily | |
IPR009051 | Alpha-helical ferredoxin | Homologous Superfamily | |
IPR017900 | 4Fe-4S ferredoxin, iron-sulphur binding, conserved site | Conserved Site | |
IPR028261 | Dihydroprymidine dehydrogenase domain II | Domain | |
IPR017896 | 4Fe-4S ferredoxin-type, iron-sulphur binding domain | Domain | |
IPR023753 | FAD/NAD(P)-binding domain | Domain |
Structure Motif Annotation: Mechanism and Catalytic Site Atlas M-CSA Database Homepage
Chains | Enzyme Name | Description | Catalytic Residues |
---|---|---|---|
dihydropyrimidine dehydrogenase (NADP+) M-CSA #800 | Mammalian dihydropyrimidine dehydrogenase catalyses the reduction of uracil or thymine to dihydrouracil or dihydrothymine respectively. This reaction represents an important step in the pathway of pyrimidine degradation in cells, but is particularly important to medicine because the anticancer drug 5-flourouracil, though shown to be effective, is also a substrate for this enzyme, thus its effectiveness is reduced. The development of specific inhibitors is therefore paramount in order to reduce the cost and side effects of treatment with this drug. | EC: 1.3.1.2 (PDB Primary Data) |